Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Hemophilia A Patient and Physician Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry

NCT03603275 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03603275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03603275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Hemophilia A Patient and Physician Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry
Lead sponsor
Bayer
Phase
Observational
Overall status
Terminated
Start date
August 6, 2018
Completion date
May 14, 2020
Enrollment
3 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a